Ziftomenib; KO 539

Lub npe tshuaj:

(S)-4-Methyl-5-((4-(((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno(2,3-d)pyrimidin-4-yl)amino)piperidin -1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indole-2-carbonitrile

SMILES Code:

N#CC(N1C[C@@H](N2CCN(S(=O)(C)=O)CC2)C)=CC3=C1C=CC(CN4CCC(NC5=C(C=C(F))) (F)F)S6)C6=NC(NC)=N5)CC4)=C3C

InChi Code:

InChI=1S/C33H42F3N9O2S2/c1-21(43-11-13-44(14-12-43)49(4,46)47)19-45-25(18-37)15-27-22(2) 23(5-6-29(27)45)20-42-9-7-24(8-10-42)39-30-28-16-26(17-33(34,35)36)48- 31(28)41-32(38-3)40-30/h5-6,15-16,21,24H,7-14,17,19-20H2,1-4H3,(H2,38,39,40 ,41)/t21-/m0/s1

InChi Key:

BGGALFIXXQOTPY-NRFANRHFSA-N

Lo lus tseem ceeb:

2134675-36-6; CAS: 2134675-36-6; CAS: 2134675-36-6; Ziftomenib; KO 539; KO 539; TSI-539

Solubility:Yuav txiav txim siab

Cia:Qhuav, tsaus thiab ntawm 0 - 4 C rau lub sijhawm luv (hnub mus rau lub lis piam) lossis -20 C rau lub sijhawm ntev (hli mus rau xyoo).

Nqe lus piav qhia:

Ziftomenib (KO-539) yog ib qho inhibitor ntawm menin MLL kev cuam tshuam nrog kev ua ntawm qhov ncauj.

Hom phiaj: menin-MLL